These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 302935)

  • 41. Spontaneous retroperitoneal hemorrhage during oral anticoagulant therapy.
    Estivill Pallejà X; Domingo P; Fontcuberta J; Félez J
    Arch Intern Med; 1985 Aug; 145(8):1531, 1534. PubMed ID: 3161482
    [No Abstract]   [Full Text] [Related]  

  • 42. [Potentiation of acenocoumarol after application of an semi-synthetic heparinoid].
    Potel G; Maulaz B; Pabceuf C; Toyze MD; Baron D
    Therapie; 1989; 44(1):67-8. PubMed ID: 2472016
    [No Abstract]   [Full Text] [Related]  

  • 43. Pharmacogenetics of acenocoumarol: cytochrome P450 CYP2C9 polymorphisms influence dose requirements and stability of anticoagulation.
    Tàssies D; Freire C; Pijoan J; Maragall S; Monteagudo J; Ordinas A; Reverter JC
    Haematologica; 2002 Nov; 87(11):1185-91. PubMed ID: 12414349
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hemorrhage while on anticoagulant therapy precipitated by drug interaction.
    Taylor PJ
    Ariz Med; 1967 Aug; 24(8):697-9. PubMed ID: 6056202
    [No Abstract]   [Full Text] [Related]  

  • 45. Assessment of therapeutic quality control in a long-term anticoagulant trial in post-myocardial infarction patients.
    Azar AJ; Deckers JW; Rosendaal FR; van Bergen PF; van der Meer FJ; Jonker JJ; Briët E
    Thromb Haemost; 1994 Sep; 72(3):347-51. PubMed ID: 7855782
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Low molecular weight heparin (enoxaparin) versus oral anticoagulant therapy (acenocoumarol) in the long-term treatment of deep venous thrombosis in the elderly: a randomized trial.
    Veiga F; Escribá A; Maluenda MP; López Rubio M; Margalet I; Lezana A; Gallego J; Ribera JM
    Thromb Haemost; 2000 Oct; 84(4):559-64. PubMed ID: 11057850
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [A retrospective survey on practice of oral anticoagulant therapy in patients with cardiovascular diseases].
    Katona A; Márk L
    Orv Hetil; 2004 Aug; 145(32):1643-7. PubMed ID: 15384862
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Acute hemorrhagic pancreatitis in the course of anticoagulant therapy. (Description of a case)].
    Nicora E
    Pathologica; 1966; 58(863):243-7. PubMed ID: 5990357
    [No Abstract]   [Full Text] [Related]  

  • 49. Overanticoagulation associated with combined use of lactulose and acenocoumarol or phenprocoumon.
    Visser LE; Penning-van Beest FJ; Wilson JH; Vulto AG; Kasbergen AA; De Smet PA; Hofman A; Stricker BH
    Br J Clin Pharmacol; 2004 Apr; 57(4):522-4. PubMed ID: 15025752
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Long-term treatment with coumarin preparations in advanced age].
    Bán A
    Z Gesamte Inn Med; 1984 Dec; 39(24):617-20. PubMed ID: 6442071
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Duration of antivitamin K therapy in venous thromboembolic disease. Certainties and uncertainties].
    Ferrari E; Schiano N; Benhamou M; Baudouy M
    Arch Mal Coeur Vaiss; 2001 Nov; 94(11 Suppl):1301-6. PubMed ID: 11794973
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Unusual complications in the course of anticoagulant therapy.
    Reussi C; Schiavi JE; Altman R; Yussem EE; Rouvier J
    Am J Med; 1969 Mar; 46(3):460-3. PubMed ID: 5780369
    [No Abstract]   [Full Text] [Related]  

  • 53. Ticrynafen: kinetics, protein binding, and effects on serum and urinary uric acid.
    Wood AJ; Bolli P; Waal-Manning HJ; Simpson FO
    Clin Pharmacol Ther; 1978 Jun; 23(6):697-702. PubMed ID: 648082
    [No Abstract]   [Full Text] [Related]  

  • 54. Amiodarone potentiates acenocoumarin.
    Fondevila C; Meschengieser S; Lazzari MA
    Thromb Res; 1989 Jan; 53(2):203-8. PubMed ID: 2922709
    [No Abstract]   [Full Text] [Related]  

  • 55. New antihypertensive diuretic approved and marketed.
    Welsh JS
    Am Pharm; 1979 Jul; 19(8):49. PubMed ID: 474404
    [No Abstract]   [Full Text] [Related]  

  • 56. [Potentiation of a vitamin K antagonist by a pefloxacin-rifampicin combination].
    Pertek JP; Helmer J; Vivin P; Kipper R
    Ann Fr Anesth Reanim; 1986; 5(3):320-1. PubMed ID: 3777560
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ticrynafen effect on warfarin protein binding in human serum.
    Slattery JT; Levy G
    J Pharm Sci; 1979 Mar; 68(3):393. PubMed ID: 423141
    [No Abstract]   [Full Text] [Related]  

  • 58. [Potentiation of the effects of acenocoumarol by a buccal gel of miconazole].
    Marotel C; Cerisay D; Vasseur P; Rouvier B; Chabanne JP
    Presse Med; 1986 Oct; 15(33):1684-5. PubMed ID: 2947119
    [No Abstract]   [Full Text] [Related]  

  • 59. Proceedings: Steric enhancement of resonance: an explanation of the anomalously high partition coefficients of some phenoxyacetic acids.
    Dearden JC; Wootton JC
    J Pharm Pharmacol; 1975 Dec; 27 Suppl?-2():30P. PubMed ID: 2704
    [No Abstract]   [Full Text] [Related]  

  • 60. [Biostimulating effect of some sulfonamides of chlorphenoxyacetic acid and chlor-phenoxypropionic acid derivatives on the biosynthesis of pencillin G].
    Jerca L; Artenie V; Ababei L
    Rev Med Chir Soc Med Nat Iasi; 1978; 82(2):347-51. PubMed ID: 705135
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.